Comparative Effectiveness Language In Stimulus Bill Raises Concerns
This article was originally published in The Gray Sheet
Executive Summary
The House Appropriations Committee Jan. 21 approved $1.1 billion to fund comparative effectiveness research as part of an economic stimulus 1package, but industry and some patient and physician groups are expressing strong reservations about the language of the bill, as well as accompanying report language
You may also be interested in...
Dueling Comparative Effectiveness Provisions Outlined In Senate Reform Bills
As health reform goes, so goes the effort to establish a long-term infrastructure for comparative effectiveness research in the U.S
Dueling Comparative Effectiveness Provisions Outlined In Senate Reform Bills
As health reform goes, so goes the effort to establish a long-term infrastructure for comparative effectiveness research in the U.S
Senate’s Comparative Effectiveness Language Emphasizes Clinical Over Cost
Comparative effectiveness research funding of $1.1 billion passed the House and got approval from the Senate Appropriations Committee as part of an $800 billion-plus economic stimulus package last week; but device firms and some patient and physician groups are pushing for the Senate language to win out when it comes time to reconcile the bills